|D029424||Pulmonary Disease, Chronic Obstructive NIH||0.41|
|D008173||Lung Diseases, Obstructive NIH||0.38|
|D012141||Respiratory Tract Infections NIH||0.17|
There is one clinical trial.
An open access study that will define and collect digital measures of coughing in multiple populations and public spaces using various means of audio data collection.
Description: Size of collected audio dataset measured as number of collected cough sounds, targeting ≥10,000 identified coughs.Measure: Dataset size Time: 14 days
Description: Identification of cough sounds by the existing mathematical model with ≥ 99% specificity and ≥ 60% sensitivityMeasure: Cough sound identification Time: 14 days
Description: Increase in the sensitivity of the mathematical model to cough sounds to ≥ 70% while retaining the specificity of ≥ 99%Measure: Improvement of the existing model Time: 14 days
Description: Determination of the level of acceptance and satisfaction of the solution by patients by means of a Standard Usability Questionnaire to provide feedback. The score ranges from 10 to 50, higher score indicating a better usability.Measure: Evaluate the usability of the application Time: 14 days
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports